Search

everythinglearnresearchcommunity

for

Search:↓

New findings suggest targeting IL-23 could treat psoriasis, skin cells can adapt to new roles, direct conversion of skin cells to blood cells may aid cell therapy, removing certain tumor cells could boost cancer immunotherapy, and melanoma may have many tumorigenic cells, not just cancer stem cells.

Specific immune cells cause alopecia areata and blocking certain proteins can prevent it.

Human thymus has stem cells that can self-renew and maintain their identity.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Tissue environment greatly affects the unique epigenetic makeup of regulatory T cells, which could impact autoimmune disease treatment.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

T-cells in alopecia areata scalp show abnormal regulation, leading to less inflammation.

TH antibodies in vitiligo and AA patients recognize the same protein parts.

HPV8 E6 gene causes growth of certain skin stem cells.

Monoclonal antibodies LT-1, LT-2, and LT-7 help diagnose certain blood cancers.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

Memory T cells in the skin balance staying put and moving into the blood, clustering around hair follicles, and increasing in number after infection.

Dormant melanoma cells in mice interact minimally with memory T cells due to a suppressive tumor environment.

People with atopic dermatitis have more CD4+ T cells that respond to a certain bacterial lipid, which may play a role in the skin condition's inflammation.

Tph cells are linked to the severity of systemic lupus erythematosus.

Targeting regulatory T cells may help treat age-related diseases.

IL-17 plays a key role in severe hair loss in chronic alopecia areata.

Targeting specific T cells may help treat alopecia areata.

Th22 cells are essential for Tβ15-induced hair growth in mice.

Regulatory T cells adapt to different environments to control inflammation and support tissue repair.

Thymus-derived Tregs, not peripherally-derived Tregs, primarily regulate type 1 diabetes in the NOD mouse model.

T cells and inflammation are crucial in atherosclerosis, with anti-inflammatory treatments showing promise.

Expanding CD4+ Tregs can stop hair loss in alopecia areata.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

Blocking IL-8 can reduce skin rashes from cancer treatment.

Treg cells help repair and regenerate tissues by interacting with local cells.

T-regulatory cells are important for skin health and can affect hair growth and reduce skin inflammation.

Giving immune serum from vaccinated mice to mice without T cells prevents infection and tumor growth.

Enhancing regulatory T cells may help treat autoimmune diseases like alopecia areata.